H. Gary Zhao
Early Diagnosis and Early Intervention in Hematology
Home
Projects
[Machine Learning] Early Diagnosis of Clonal Hematological Abnormalities
[Data-driven ] Early Intervention of Chronic Myeloid Malignancies
Publications
contact
For a full list of my publications, visit my Google Scholar profile here:
Select Publications
Zhao, H., Mleynek, T. & Li, D. Dysregulated exocytosis of angiopoietin-2 drives cerebral cavernous malformation. Nat Med (2016).
Zhao, H., Pomicter, A., Eiring, A., et al. MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis. Blood (2022).
Zhao, H.G. & Deininger, M. Always stressed but never exhausted: how stem cells in myeloid neoplasms avoid extinction in inflammatory conditions. Blood (2023).
Zhao, H. & Deininger, M. Eradicating residual chronic myeloid leukaemia: basic research lost in translation. Lancet Haematol (2021).
Zhao, H., Mendenhall, M. & Deininger, M.W. Imatinib is not a potent anti-SARS-CoV-2 drug. Leukemia (2020).
Ishida, Mercoli, Heck, et al. Differentiation latency and dormancy signatures define fetal liver hematopoietic stem cells at single-cell resolution. Cell Reports (2025).
Zhao, H.G. Should oligomonocytic CMML be classified as an independent disease entity? Br J Haematol (2024).